Delivery Order SPE2DH25D0001-SPE2D426F0449
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $4,467.00 by the Defense Logistics Agency Medical Supply Chain on November 6, 2025, with an ultimate completion date of November 10, 2025. The contract, designated as 4569947519 and described as an "EG7+ Cartridge," utilizes a fixed-price structure with economic price adjustment pricing. The award was made without a set-aside designation, indicating full and open competition....
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order contract on August 12, 2025, by the Medical Supply Chain, a defense-focused federal agency, for CG8+ Cartridge products. The contract carries a ceiling value of $2,743.75 and is structured as a fixed-price delivery order with economic price adjustment provisions. The performance location is identified as North Chicago, Illinois, which aligns with Abbott's corporate headquarters and reflects the...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,736.25 by the Defense Medical Supply Chain on October 14, 2025, for CG8+ cartridges. The contract is structured as a fixed-price agreement with economic price adjustment provisions and does not utilize any set-aside designation, indicating full and open competition. Performance is scheduled for completion by October 16, 2025, at Abbott's facility in North Chicago, Illinois. This...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,041.75 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 12, 2025. The contract covers CG8+ cartridge products and is structured as a fixed-price delivery order with economic price adjustment provisions. The award was made on September 10, 2025, with no set-aside designation, indicating full and open competition. Performance...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $4,167.00 by the Defense-affiliated Medical Supply Chain agency on August 18, 2025, with an ultimate completion date of August 20, 2025. The contract is for CG8+ cartridges and employs fixed-price pricing with economic price adjustment terms. The work will be performed in North Chicago, Illinois, the location of Abbott's headquarters. This delivery order was awarded without a set-aside...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Medical Supply Chain division of the Department of Defense on August 29, 2025, with an ultimate completion date of September 3, 2025. The contract, designated as 4569273740 for a CG8+ Cartridge, utilizes fixed-price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order represents a task order call against a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,104.75 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025, with completion expected by September 10, 2025. The contract covers CG8+ Cartridge products and utilizes fixed-price pricing with economic price adjustment terms. The award was made without a set-aside designation, indicating full and open competition. Performance of this delivery order will take place...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,247.84 on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract, designated as a Fixed Price with Economic Price Adjustment delivery order, calls for the supply of CG8+ cartridges to support federal healthcare operations. The work will be performed in North Chicago, Illinois, with an ultimate completion date of September 8, 2025. This award was...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order contract by the Medical Supply Chain (Defense) agency on June 24, 2025, for CG8+ cartridges. The contract is valued at $1,389.00 and carries a fixed-price structure with economic price adjustment provisions. Work will be performed in North Chicago, Illinois. This delivery order was awarded without set-aside designation, indicating full and open competition among qualified vendors. This delivery...
- Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order valued at $1,448.76 by the Defense Medical Supply Chain for the procurement of CG8+ Cartridge products. The contract, awarded on September 9, 2025, with an ultimate completion date of September 11, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, indicating full and open competition. The place of performance is...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D426F0449Delivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $4,451.76 on October 24, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as CG8+ Cartridge with a fixed-price structure including economic price adjustment provisions, has an ultimate completion date of October 28, 2025. Performance will be conducted at Abbott's facility in North Chicago, Illinois. No small business set-aside was utilized for this award, which reflects the full and open competitive procurement approach typical of Abbott's federal contracting engagements. This delivery order represents a continuation of Abbott's extensive federal healthcare supplier relationship, specifically supporting the Defense Logistics Agency Medical Supply Chain's procurement of diagnostic consumables. Abbott maintains a substantial portfolio of indefinite delivery vehicles across multiple Veterans Integrated Service Networks and Defense Health Agency contracts, through which the company supplies point-of-care testing devices, i-STAT cartridges, chemistry panels, and diagnostic reagents. The CG8+ Cartridge delivery order aligns with Abbott's established role as a critical supplier of medical diagnostic products and consumables to federal healthcare systems, leveraging the company's existing blanket purchase agreements and GSA schedule contracts that collectively represent tens of millions in available ceiling values across government healthcare procurement channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 10/24/25 |